The Laboratory tubes

Samfura

Tofacitinib citrate 540737-29-9 Rheumatoid amosanin gabbai Anticancer

Takaitaccen Bayani:

Makamantuwa:CP-690550 (Tofacitinib citrate); (3R,4R) -1- (Cyanoacetyl) -4-methyl-N-methyl-N-1H-pyrrolo [2,3-d] pyrimidin-4-yl-3-piperidinamine 2 -hydroxy-1,2,3-propanetricarboxylate

Lambar CAS:540737-29-9

inganci:cikin gida

Tsarin kwayoyin halitta:Saukewa: C16H20N6O.C6H8O7

Nauyin Formula:504.49


Cikakken Bayani

Tags samfurin

Biya:T/T, L/C
Asalin samfur:China
Tashar Jirgin Ruwa:Beijing/Shanghai/Hangzhou
Ƙarfin samarwa:100kg/wata
Oda (MOQ):25kg
Lokacin Jagora:3 Ranakun Aiki
Yanayin ajiya:Ajiye a wuri mai sanyi, busasshiyar wuri, zazzabin ɗaki.
Kunshin kayan:ganga
Girman kunshin:25kg/ganga
Bayanin aminci:Ba kayan haɗari ba

Tofacitinib citrate

Gabatarwa

Tofacitinib, magani ne da ake amfani da shi don magance cututtukan cututtuka na rheumatoid, psoriatic arthritis, da ulcerative colitis.

Ana amfani da Tofacitinib citrate don bi da manya tare da matsakaici zuwa matsananciyar aiki na rheumatoid amosanin gabbai waɗanda basu da isasshen amsa ga, ko waɗanda ba su da haƙuri, methotrexate.

Tofacitinib citrate ana nuna shi don kula da matsakaici zuwa matsananciyar aiki na rheumatoid amosanin gabbai (RA) a cikin manya waɗanda ba su amsa da kyau ba, ko kuma waɗanda ba su da haƙuri ga ɗaya ko fiye da magungunan antirheumatic masu gyara cututtuka.

Ƙayyadewa (a cikin gida)

Abu

Ƙayyadaddun bayanai

Bayyanar

Farar ko kashe-fari crystalline foda

Ganewa

IR, HPLC

Ruwa

≤1.5%

Abubuwa masu alaƙa

TOFA 06 ≤0.15%

Tofacitinib trans isomer ≤0.15%

Tofacitinib dehydrogenated ≤0.15%

Kowane ƙazanta da ba a sani ba ≤0.10%

Jimlar ƙazanta: ≤1.0%

Ragowar Magani

Ethanol ≤5000ppm

Benzene ≤2ppm

Toluene ≤890ppm

Chlroroethane ≤1000ppm

N, N-Dimethylformamide ≤800ppm

Palladium ≤10ppm

Dichloromethane ≤600ppm

Sulfate ash

≤0.1%

Karfe mai nauyi

≤10pm

Farashin HPLC

3S, 4S tofacitinib ≤0.15%

Assay (a kan anhydrous tushen) 98.0-102.0%


  • Na baya:
  • Na gaba: